Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
November 5, 2020
In oncology, many manufacturers go into niche indications, where there are very specific tumors, and then they opt for...
Read article
October 22, 2020
An Interview with Bart Heeg (Part 2): New Trends in HEOR
In this two-part blog series, we interview Bart Heeg, Vice President HEOR and Founder at Ingress Health (A Cytel...
Read article
October 14, 2020
The Increasing Importance of Health Economics
A credible evidence base is needed to support and document the economic value of new technologies and therapeutic...
Read article
April 13, 2016
HTAs: Adjusting Overall Survival for Treatment Switch
We continue our series of blogs covering the expert presentations from the EAST User Group Meeting. Consultant Claire...
Read article